Patient advocacy and involvement stories

Polycystic Ovary Syndrome Renamed to Polyendocrine Metabolic Ovarian Syndrome After Global Consensus

After more than a decade of discussion, polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS) through a global consensus process involving patients and clinicians. The change affects a condition impacting approximately 170 million women worldwide and is expected to improve diagnosis and treatment.